All Comments by A. David Smith
- Biogen/Eisai Halt Phase 3 Aducanumab Trials
- Neither Exercise Nor Supplements Boost Cognition in Two Large Studies
- Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.
- Testing the right target and right drug at the right stage.
- Resolving controversies on the path to Alzheimer's therapeutics.
- Toronto: 6th Sense—GWAS Picks Up New AD Risk Variant
- Research Brief—Flurizan Fails Final Hurdle, Company Discontinues Drug
- Could linear MRI measurements of hippocampus differentiate normal brain aging in elderly persons from Alzheimer disease?
- Higher estrogen levels are not associated with larger hippocampi and better memory performance.
- Vascular Disease, Parkinson's, and Now Alzheimer's—Is Homocysteine the New All-Around Bad Guy?